Literature DB >> 24071793

ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013.

Sarah T South1, Charles Lee, Allen N Lamb, Anne W Higgins, Hutton M Kearney.   

Abstract

Microarray methodologies, including array comparative genomic hybridization and single-nucleotide polymorphism-detecting arrays, are accepted as an appropriate first-tier test for the evaluation of imbalances associated with intellectual disability, autism, and multiple congenital anomalies. This technology also has applicability in prenatal specimens. To assist clinical laboratories in validation of microarray methodologies for constitutional applications, the American College of Medical Genetics and Genomics has produced the following revised professional standards and guidelines.

Entities:  

Mesh:

Year:  2013        PMID: 24071793     DOI: 10.1038/gim.2013.129

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  100 in total

Review 1.  Copy number variants, aneuploidies, and human disease.

Authors:  Christa Lese Martin; Brianne E Kirkpatrick; David H Ledbetter
Journal:  Clin Perinatol       Date:  2015-04-01       Impact factor: 3.430

2.  Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil.

Authors:  Patrícia Ashton-Prolla; José Roberto Goldim; Filippo Pinto E Vairo; Ursula da Silveira Matte; Jorge Sequeiros
Journal:  J Community Genet       Date:  2015-06-04

3.  Genetic and expression changes in TNF-α as a risk factor for rheumatoid arthritis pathogenesis in northeast India.

Authors:  Somdatta Das; Chitralekha Baruah; Anjan Kumar Saikia; Diptika Tiwari; Sujoy Bose
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

4.  Chromosomal Microarray Detection of Constitutional Copy Number Variation Using Saliva DNA.

Authors:  Jennifer Reiner; Lisa Karger; Ninette Cohen; Lakshmi Mehta; Lisa Edelmann; Stuart A Scott
Journal:  J Mol Diagn       Date:  2017-03-18       Impact factor: 5.568

5.  Describing sequencing results of structural chromosome rearrangements with a suggested next-generation cytogenetic nomenclature.

Authors:  Zehra Ordulu; Kristen E Wong; Benjamin B Currall; Andrew R Ivanov; Shahrin Pereira; Sara Althari; James F Gusella; Michael E Talkowski; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2014-04-17       Impact factor: 11.025

6.  Genomic Disorders and Neurocognitive Impairment in Pediatric CKD.

Authors:  Miguel Verbitsky; Amy J Kogon; Matthew Matheson; Stephen R Hooper; Craig S Wong; Bradley A Warady; Susan L Furth; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 10.121

7.  Genetic Testing and Pregnancy Outcome Analysis of 362 Fetuses with Congenital Heart Disease Identified by Prenatal Ultrasound.

Authors:  Shiyu Luo; Dahua Meng; Qifei Li; Xuehua Hu; Yuhua Chen; Chun He; Bobo Xie; Shangyang She; Yingfeng Li; Chunyun Fu
Journal:  Arq Bras Cardiol       Date:  2018-08-20       Impact factor: 2.000

Review 8.  Clinical utility of genomic sequencing.

Authors:  Matthew B Neu; Kevin M Bowling; Gregory M Cooper
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

9.  Detection of Copy Number Variants by Short Multiply Aggregated Sequence Homologies.

Authors:  Vaidehi Jobanputra; Peter Andrews; Vanessa Felice; Avinash Abhyankar; Lukasz Kozon; Dino Robinson; Ferrah London; Inessa Hakker; Kazimierz Wrzeszczynski; Michael Ronemus
Journal:  J Mol Diagn       Date:  2020-10-23       Impact factor: 5.568

Review 10.  Genetic testing for kidney disease of unknown etiology.

Authors:  Thomas Hays; Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2020-04-24       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.